These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Mechanisms of the Metabolic Shift during Somatic Cell Reprogramming. Nishimura K; Fukuda A; Hisatake K Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067778 [TBL] [Abstract][Full Text] [Related]
7. Multiple Roles of MYC in Integrating Regulatory Networks of Pluripotent Stem Cells. Fagnocchi L; Zippo A Front Cell Dev Biol; 2017; 5():7. PubMed ID: 28217689 [TBL] [Abstract][Full Text] [Related]
8. Pluripotent stem cell energy metabolism: an update. Teslaa T; Teitell MA EMBO J; 2015 Jan; 34(2):138-53. PubMed ID: 25476451 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CCDC144NL-AS1 knockdown induces naïve-like state conversion of human pluripotent stem cells. Wang Y; Guo B; Xiao Z; Lin H; Zhang X; Song Y; Li Y; Gao X; Yu J; Shao Z; Li X; Luo Y; Li S Stem Cell Res Ther; 2019 Jul; 10(1):220. PubMed ID: 31358062 [TBL] [Abstract][Full Text] [Related]
10. Linking Telomere Regulation to Stem Cell Pluripotency. Liu L Trends Genet; 2017 Jan; 33(1):16-33. PubMed ID: 27889084 [TBL] [Abstract][Full Text] [Related]
11. Metabolic plasticity during transition to naïve-like pluripotency in canine embryo-derived stem cells. Tobias IC; Isaac RR; Dierolf JG; Khazaee R; Cumming RC; Betts DH Stem Cell Res; 2018 Jul; 30():22-33. PubMed ID: 29778974 [TBL] [Abstract][Full Text] [Related]
13. Resetting Human Naïve Pluripotency. Xiao J; Mai DH; Xie L Genet Epigenet; 2016; 8():37-41. PubMed ID: 27512340 [TBL] [Abstract][Full Text] [Related]
14. Lipid Deprivation Induces a Stable, Naive-to-Primed Intermediate State of Pluripotency in Human PSCs. Cornacchia D; Zhang C; Zimmer B; Chung SY; Fan Y; Soliman MA; Tchieu J; Chambers SM; Shah H; Paull D; Konrad C; Vincendeau M; Noggle SA; Manfredi G; Finley LWS; Cross JR; Betel D; Studer L Cell Stem Cell; 2019 Jul; 25(1):120-136.e10. PubMed ID: 31155483 [TBL] [Abstract][Full Text] [Related]
15. Metabolism in Human Pluripotent Stem Cells and Cardiomyocytes for Regenerative Therapy. Umei TC; Tohyama S Keio J Med; 2022 Sep; 71(3):55-61. PubMed ID: 35082186 [TBL] [Abstract][Full Text] [Related]
16. The combination of dibenzazepine and a DOT1L inhibitor enables a stable maintenance of human naïve-state pluripotency in non-hypoxic conditions. Isono W; Kawasaki T; Ichida JK; Ayabe T; Hiraike O; Umezawa A; Akutsu H Regen Ther; 2020 Dec; 15():161-168. PubMed ID: 33426214 [TBL] [Abstract][Full Text] [Related]
18. Concise Review: Control of Cell Fate Through Cell Cycle and Pluripotency Networks. Boward B; Wu T; Dalton S Stem Cells; 2016 Jun; 34(6):1427-36. PubMed ID: 26889666 [TBL] [Abstract][Full Text] [Related]
19. DNA Methylation is Correlated with Pluripotency of Stem Cells. Wang R; Li T Curr Stem Cell Res Ther; 2017; 12(6):442-446. PubMed ID: 28025937 [TBL] [Abstract][Full Text] [Related]
20. Decoding molecular markers and transcriptional circuitry of naive and primed states of human pluripotency. Ghosh A; Som A Stem Cell Res; 2021 May; 53():102334. PubMed ID: 33862536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]